肺癌中的炎症标志物:预后和预测价值
Paschalina Tsopa1, Nikolaos Syrigos1, Christos Kosmas2
1Oncology Department, 3rd Internal Medicine Department "Sotiria" Hospital, National and Kapodestrian University of Athens.
概括
像C反应蛋白这样的炎症标志物对于了解肺癌进展至关重要. 本综述总结了关键标记和得分,以改善肺癌患者的预后和治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物标志物研究 生物标志物研究
背景情况:
- 肺癌是全球主要的死亡原因,其特点是复杂的炎症过程.
- 炎症标志物,包括蛋白质,细胞和基因,在肺癌的发展和进展中起着重要作用.
研究的目的:
- 审查肺癌中常被研究的炎症标志物.
- 总结非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC) 的预后和预测得分和指数.
- 讨论炎症标志物在指导肺癌精准医学中的潜力.
主要方法:
- 关于肺癌炎症标志物的现有文献的叙述性综述.
- 专注于C反应蛋白,瘤亡因子家族和前列腺素E合成酶3.
- 重点是基于临床实践的评分和指数,用于预后和预测价值.
主要成果:
- 几种炎症标志物和临床评分表明肺癌的预后和预测潜力.
- 这些标记可以表明整体存活率,治疗反应和瘤免疫特征.
- 更简单,更具成本效益的临床分数显示出对常规应用的希望.
结论:
- 炎症标志物和衍生的分数是肺癌管理的宝贵工具.
- 测试标准化和响应复杂性等局限性需要解决.
- 生物技术和临床见解的进步可以提高肺癌精准医学的标记器实用性.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.9K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
715
相关概念视频
01:13Radiological Investigation III: Pulmonary Angiogram and PET Scan
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...